JP Morgan Chase
BHVN icon

JP Morgan Chase’s Biohaven BHVN Stock Holding History

JP Morgan Chase’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30,000
Closed -$780K – 7523
2023
Q3 		$780K Buy
+30,000
New +$624K ﹤0.01% 4233

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase's BHVN Position: Q2 2026 in Review

JP Morgan Chase reduced its Biohaven (BHVN) stake by 6.7% in Q2 2026, selling an estimated $363K and leaving 469,832 shares worth $7.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3117.

JP Morgan Chase first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $73.9M in Q4 2024. 168 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • JP Morgan Chase held 469,832 shares of Biohaven worth $7.11M as of Q2 2026.
  • JP Morgan Chase sold 33,733 Biohaven shares in Q2 2026, an estimated $363K.
  • Biohaven made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3117 holding.
  • JP Morgan Chase first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • JP Morgan Chase's Biohaven position peaked at $73.9M in Q4 2024.
  • 168 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.